BRN2 expression increases anoikis resistance in melanoma

Carly J. Pierce(QIMR Berghofer Medical Research Institute), Glen M. Boyle(Queensland University of Technology)

Oncogenesis

July 6, 2020

10.1038/s41389-020-00247-1

Cited by 36

Related Papers

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

|Nature|2011|474

Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models

|PLoS ONE|2014|86

MITF and BRN2 contribute to metastatic growth after dissemination of melanoma

|Scientific Reports|2017|63

BRN2 and MITF together impact AXL expression in melanoma

|bioRxiv (Cold Spring Harbor Laboratory)|2020|0